Organo Corp.

Organo Corp.'s next confirmed earnings release is scheduled for November 4, 2026.

As of March 31, 2026, Organo Corp. has 230.46M shares outstanding.

As of March 31, 2026, Organo Corp. maintains a current ratio of 2.71, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of March 31, 2026, Organo Corp. holds 535.09M in cash and equivalents against 216.80M in total debt, resulting in a net debt position of 21.09M. Total book value stands at 900.92M, with working capital of 762.92M providing operational flexibility.